Serum Institute: The World's Largest Vaccine Maker

Imagine a single privately-owned, Pune-based company, Serum Institute of India, producing more vaccine doses annually than any other manufacturer on the entire planet, over 1.3 billion doses covering vaccines against BCG, polio, Hib, DTaP and MMR among others, a scale of production that made Serum Institute genuinely central to global vaccine access well before its Covishield COVID-19 vaccine production brought it broader public recognition during the pandemic.

This scale rests directly on WHO-GMP certified manufacturing capability, covered elsewhere on this site under the broader quality certification discussion, vaccine manufacturing carries genuinely more stringent process and sterility requirements than conventional pharmaceutical formulation, meaning Serum Institute's ability to maintain this certification across its enormous production volume represents a genuine, sustained quality management achievement, not simply a scale advantage.

Serum Institute's business model has historically depended significantly on serving global public health procurement, supplying vaccines to UNICEF, Gavi and national immunisation programmes across developing countries at genuinely affordable prices, a volume-driven, lower-margin-per-dose model that only works economically at Serum Institute's enormous manufacturing scale, illustrating a genuinely different economic logic than the branded or specialty pharmaceutical manufacturing covered elsewhere on this site.

This vaccine manufacturing capability connects directly to India's broader pharmaceutical export identity covered throughout this page, Serum Institute's global public health role gives India genuine, distinctive standing in vaccine diplomacy and global health security discussions, well beyond the generic drug export volume, covered elsewhere on this site, that otherwise dominates how India's pharmaceutical industry gets characterised internationally, a genuinely different and arguably more strategically significant dimension of India's pharmaceutical manufacturing story.